References
- Ali A, Waly MI, Al-Farsi YM, Essa MM, Al-Sharbati MM, Deth RC. 2011. Hyperhomocysteinemia among Omani autistic children: A case control study. Acta Biochim Pol. 58:547–551 doi:https://doi.org/10.18388/abp.2011_2223.
- American Psychiatric Association (APA). (2013). Diagnostic and statistical manual of mental disorders. 5th ed. (DSM-5). USA: American Psychiatric Publishing.
- Andersen SL. 2003. Trajectories of brain development: Point of vulnerability or window of opportunity? Neurosci Biobehav Rev. 27:3–18 doi:https://doi.org/10.1016/s0149-7634(03)00005-8.
- Beard RS, Reynolds JJ, Bearden SE. 2011. Hyperhomocystei-nemia increases permeability of the blood-brain barrier by NMDA receptor-dependent regulation of adherens and tight junctions. Blood. 118:2007–2014. doi:https://doi.org/10.1182/blood-2011-02-338269.
- Bertisch SM, Pollock BD, Mittleman MA, Buysse DJ, Bazzano LA, Gottlieb DJ, Redline S. 2018. Insomnia with objective short sleep duration and risk of incident cardiovascular disease and all-cause mortality: Sleep heart health study. Sleep. 41:6. doi:https://doi.org/10.1093/sleep/zsy047.
- Beydoun MA, Gamaldo AA, Canas JA, Beydoun HA, Shah MT, McNeely JM, Zonderman AB. 2014. Serum nutritional biomarkers and their associations with sleep among US adlts in recent national surveys. PLoS On. 9(8):e103490. doi:https://doi.org/10.1371/journal.pone.0103490.
- Bollmann S, Ghisleni C, Poil SS, Martin E, Ball J, Eich-Höchli D, Edden RAE, Klaver P, Michels L, Brandeis D, et al. 2015. Developmental changes in gamma-aminobutyric acid levels in attention-deficit/hyperactivity disorder. Transl Psychiatry. 5(6):e589. doi:https://doi.org/10.1038/tp.2015.79.
- Boy F, Evans CJ, Edden RA, Lawrence AD, Singh KD, Husain M, Sumner P. 2011. Dorsolateral prefrontal gamma-aminobutyric acid in men predicts individual differences in rash impulsivity. Biol Psychiatry. 70:866–872. doi:https://doi.org/10.1016/j.biopsych.2011.05.030.
- Carpena MX, Bonilla C, Matijasevich A, Martins-Silva T, Genro JP, Hutz MH, Rohde LA, Tovo-Rodrigues L. 2021. Sleep-related traits and attention-deficit/hyperactivity disorder comorbidity: Shared genetic risk factors, molecular mechanisms, and causal effects. World J Biol Psychiatry. 30:1–14. doi:https://doi.org/10.1080/15622975.2021.1907719.
- Comai S, Tau M, Gobbi G. 2012a. The psychopharmacology of aggressive behavior: A translational approach: Part 1: Neurobiology. J Clin Psychopharmacol. 32:83–94. doi:https://doi.org/10.1097/JCP.0b013e31823f8770.
- Comai S, Tau M, Pavlovic Z, Gobbi G. 2012b. The psychopharmacology of aggressive behavior: A translational approach: Part 2: Clinicalstudies using atypical antipsychotics, anticonvulsants, and lithium. J Clin Psychopharmacol. (b)32:237–260. doi:https://doi.org/10.1097/JCP.0b013e31824929d6.
- Coogan AN, McGowan NMJAAD. 2017. A systematic review of circadian function, chronotype and chronotherapy in attention deficit hyperactivity disorder. 9(3):129–147. doi:https://doi.org/10.1007/s12402-016-0214-5.
- Courvoisie H, Hooper SR, Fine C, Kwock L, Castillo M. 2004. Neurometabolic functioning and neuropsychological correlates in children with ADHD-H: Preliminary findings. J Neuropsychiatr Clin Neurosci. 16:63–69. doi:https://doi.org/10.1176/jnp.16.1.63.
- Dursun OB, Ogutlu H, Esin IS. 2015. Turkish validation and adaptation of children’s chronotype questionnaire (CCTQ). Eurasian J Med. 47:56. doi:https://doi.org/10.5152/eajm.2014.0061.
- Ende G, Cackowski S, Van Eijk J, Sack M, Demirakca T, Kleindienst N, Bohus M, Sobanski E, Krause-Utz A, Schmahl C, et al. 2016. Impulsivity and aggression in female BPD and ADHD patients: Association with ACC glutamate and GABA concentrations. Neuropsychopharmacology. 41:410–418. doi:https://doi.org/10.1038/npp.2015.153.
- Ercan ES, Amado S, Somer O, Cikoglu S. 2001. Development of a test battery for the assessment of attention deficit hyperactivity disorder [Article in Turkish]. Turk J Child Adolesc Ment Health. 8:132–144.
- Fiş NP, Arman A, Ay P, Topuzoglu A, Gueler AS, Imren SG, Ersu R, Berkem M. 2010. Reliability and validity of Turkish sleep disturbance scale for children. Anatolian J Psychiatry. 11:151–160. doi:https://doi.org/10.5455/apd.65084.
- The NEATS; Gilgun JF. 2011. A child & family assessment. USA: Creat Space Publishing.
- Gökler B, Ünal F, Pehlivantürk B, Kültür EÇ, Akdemir D, Taner Y. 2004. Reliability and validity of schedule for affective disorders and schizophrenia for school age children-present and lifetime version-turkish version (K-SADS-PL-T). Turk J Child Adolesc Ment Health. 11(3):109–116.
- Golan N, Shahar E, Ravid S, Pillar GJS. 2004. disorders and daytime sleepiness in children with attention-deficit/hyperactive disorder. Sleep. 27(2):261–266. doi:https://doi.org/10.1093/sleep/27.2.261.
- Graham IM, Daly LE, Refsum HM, Robinson K, Brattström LE, Ueland PM, Palma-Reis RJ, Boers GH, Sheahan RG, Israelsson B, et al. 1997. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA. 277(22):1775–1781. doi:https://doi.org/10.1001/jama.1997.03540460039030.
- Hai T, Swansburg R, Kahl CK, Frank H, Lemay JF, MacMaster FP. 2020 1. Magnetic resonance spectroscopy of γ-aminobutyric acid and glutamate concentrations in children with attention-deficit/hyperactivity disorder. JAMA Netw Open. 3(10):e2020973. doi:https://doi.org/10.1001/jamanetworkopen.2020.20973.
- Hoerst M, Weber-Fahr W, Tunc-Skarka N, Ruf M, Bohus M, Schmahl C, Ende G. 2010. Correlation of glutamate levels in the anterior cingulate cortex with self-reported impulsivity in patients with borderline personality disorder and healthy controls. Arch Gen Psychiatry. 67:346–354. doi:https://doi.org/10.1001/archgenpsychiatry.2010.93.
- Hollander E, Evers M. 2001. New developments in impulsivity. Lancet. 358:949–950. doi:https://doi.org/10.1016/S0140-6736(01)06114-1.
- Huskisson E, Maggini S, Ruf M. 2007. The influence of micronutriens on cognitive function and performance. J Int Med Res. 35(1):1–19. doi:https://doi.org/10.1177/147323000703500101.
- Jagadapillai R, Mellen NM, Sachleben LR Jr, Gozal E. 2014. Ceftriaxone preserves glutamate transporters and prevents intermittent hypoxia-induced vulnerability to brain excitotoxic injury. PLoS One. 9:e100230. doi:https://doi.org/10.1371/journal.pone.0100230.
- Jalloh K, Roeder N, Hamilton J, Delis F, Hadjiargyrou M, Komatsu D, Thanos PK. 2021. Chronic oral methylphenidate treatment in adolescent rats promotes dose-dependent effects on NMDA receptor binding. Life Sci. 1(264):118708. doi:https://doi.org/10.1016/j.lfs.2020.118708.
- Jones BE, Kryger ME, Roth T, Dement WC. 2005. Principles and practice of sleep Medicine. Philadelphia: Elsevier.
- Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N. 1997. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL). Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 36(7):980–988. doi:https://doi.org/10.1097/00004583-199707000-00021.
- Kawwass JF, Sanders KM, Loucks TL, Rohan LC, Berga SL. 2017. Increased cerebrospinal fluid levels of GABA, testosterone and estradiol in women with poly-cystic ovary syndrome. Hum Reprod. 32(7):1450–1456. doi:https://doi.org/10.1093/humrep/dex086.
- Khan MS, Aouad R. 2017. The effects of insomnia and sleep loss on cardiovascular disease. Sleep Med Clin. 12:167–177. doi:https://doi.org/10.1016/j.jsmc.2017.01.005.
- Krantis A. 1990. Selective uptake of gamma-aminobutyric acid by neural elements and vascular nerves of the rat intestinal submucosa. Neurosci Lett. 109:1–6. doi:https://doi.org/10.1016/0304-3940(90)90528-H.
- Namjoo I, Alavi Naeini A, Najafi M, Aghaye Ghazvini MR, Hasanzadeh A. 2020. The relationship between antioxidants and inflammation in children with attention deficit hyperactivity disorder. Basic Clin Neurosci. 11(3):313–321. doi:https://doi.org/10.32598/bcn.11.2.1489.1.
- Owens JA, Spirito A, McGuinn M. 2000. The children’s sleep habits questionnaire (CSHQ): Psychometric properties of a survey instrument for school-aged children. Sleep-New York. 23:1043–1052. doi:https://doi.org/10.1037/t33022-000.
- Ozdogan MG, Aydin EF, Ustundag MF, Akgul Ceyhun H, Oral E, Bakan E. 2020. Homocysteine,chronotype and clinical course in bipolar disorder patients. Nord J Psychiatry. 74(5):340–345. doi:https://doi.org/10.1080/08039488.2019.1710250.
- Puts NA, Ryan M, Oeltzschner G, Horska A, Edden RAE, Mark Mahone E. 2020. Reduced striatal GABA in unmedicated children with ADHD at 7T. Psychiatry Res Neuroimaging. 30(301):111082. doi:https://doi.org/10.1016/j.nicl.2017.06.003.
- Reis HJ, Guatimosim C, Paquet M, Santos M, Ribeiro FM, Kummer A, Schenatto G, Salgado JV, Vieira LB, Teixeira AL, et al. 2009. Neuro-transmitters in the central nervous system & their implication in learning and memory processes. Curr Med Chem. 16:796–840. doi:https://doi.org/10.2174/092986709787549271.
- Sacchetti GM, Lefler EK. 2014. ADHD symptomology and social functioning in college students. J Atten Disord. doi:https://doi.org/10.1177/1087054714557355. pii: 1087054714557355. (Epub ahead of print).
- Saha T, Chatterjee M, Verma D, Ray A, Sinha S, Rajamma U, Mukhopadhyay K. 2018. Genetic variants of the folate metabolic system and mild hyperhomocysteinemia may affect ADHD associated behavioral problems. Prog Neuropsychopharmacol Biol Psychiatry. 84:1–10. doi:https://doi.org/10.1016/j.pnpbp.2018.01.016.
- Schmitz F, Pierozan P, Rodrigues AF, Biasibetti H, Coelho DM, Mussulini BH, Pereira MSL, Parisi MM, Barbé-Tuana F, de Oliveira DL, et al. 2015. Chronic treatment with a clinically relevant dose of methylphenidate increases glutamate levels in cerebrospinal fluid and impairs glutamatergic homeostasis in prefrontal cortex of juvenile rats. Mol Neurobiol. 53:2384–2396. doi:https://doi.org/10.1007/s12035-015-9219-x.
- Silveri MM, Sneider JT, Crowley DJ, Covell MJ, Acharya D, Rosso IM, Jensen JE. 2013. Frontal lobe γ-aminobutyric acid levels during adolescence: Associations with impulsivity and response inhibition. Biol Psychiatry. 74(4):296–304. doi:https://doi.org/10.1016/j.biopsych.2013.01.033.
- Skalny AV, Mazaletskaya AL, Zaitseva IP, Skalny A, Spandidos D, Tsatsakis A, Lobanova Y, Skalnaya M, Aschner M, Tinkov A, et al. 2021. Alterations in serum amino acid profiles in children with attention deficit/hyperactivity disorder. Biomed Rep. 14(5):47. doi:https://doi.org/10.3892/br.2021.1423.
- Solleveld MM, Schrantee A, Puts NAJ, Reneman L, Lucassen PJ. 2017. Age dependent, lasting effects of methylphenidate on the GABAergic system of ADHD patients. NeuroImage Clin. 15:812–818. doi:https://doi.org/10.1016/j.nicl.2017.06.003.
- Susman EJ, Dockray S, Schiefelbein VL, Herwehe S, Heaton JA, Dorn LD. 2007. Morningness/eveningness, morning-to-afternoon cortisol ratio, and antisocial behavior problems during puberty. Dev Psychol. 43:811–822. doi:https://doi.org/10.1037/0012-1649.43.4.811.
- Tseng FC, Huang TC. 2021 20. Using data mining technology to explore homocysteine at low levels. Medicine (Baltimore). 100(33):e26893. doi:https://doi.org/10.1097/MD.0000000000026893.
- Turgay A. 1994. Disruptive behavior disorders: Child and adolescent screening and rating scales for children, adolescents, parents and teachers. West Bloomfield, MI: Integrative Therapy Institute.
- Xu X, Breen G, Chen CK, Huang YS, Wu YY, Asherson P. 2010. Association study between a polymorphism at the 3′-untranslated region of CLOCK gene and attention deficit hyperactivity disorder. Behav Brain Funct. 6:35–38. doi:https://doi.org/10.1186/1744-9081-6-48.
- Yazıcı K, Yazıcı AE. 2010. Neuroanatomical and neurochemical basis of impulsivity. Curr Approaches Psychiatry. 2:254–280.
- Yektaş Ç, Alpay M, Tufan AE. 2019. Comparison of serum B12, folate and homocysteine concentrations in children with autism spectrum disorder or attention deficit hyperactivity disorder and healthy controls. Neuropsychiatr Dis Treat. 6(15):2213–2219. doi:https://doi.org/10.2147/NDT.S212361
- Zavada A, Gordijn MC, Beersma DG, Daan S, Roenneberg T. 2005. Comparison of the Munich Chronotype Questionnaire with the Horne‐Östberg’s morningness‐eveningness score. Chronobiol Int. 22:267–278. doi:https://doi.org/10.1081/CBI-200053536